1.0EMUC25https://emuc.orgMarc van Gurphttps://emuc.org/author/houtlust/rich600338<blockquote class="wp-embedded-content" data-secret="LSu3r7lcU6"><a href="https://emuc.org/new-trial-results-for-peace-1-opera-and-adjuvant-therapies-in-high-risk-rcc/">New trial results for PEACE-1, OpeRa, and adjuvant therapies in high-risk RCC</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://emuc.org/new-trial-results-for-peace-1-opera-and-adjuvant-therapies-in-high-risk-rcc/embed/#?secret=LSu3r7lcU6" width="600" height="338" title="“New trial results for PEACE-1, OpeRa, and adjuvant therapies in high-risk RCC” — EMUC25" data-secret="LSu3r7lcU6" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> https://emuc.org/wp-content/uploads/2022/11/Prof.-Grimm.jpg17731182A selection of new trial results were shared and discussed in Plenary Session 5 on day three of EMUC22. Urologist Prof. Arnulf Stenzl (DE) and oncologists Prof. Karim Fizazi (FR) and Prof. Gert de Meerleer (BE) chaired the session, with presenters and discussants delving into the latest outcomes for PEACE-1, OpeRa, Adjuvant therapies in high-risk RCC, Effect of robot-assisted radical […]